Innovotech Inc (IOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Innovotech Inc (IOT) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$50.75K ≈ $36.71K USD) by net assets (CA$3.25 Million ≈ $2.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See IOT equity financing ratio to measure how much of total assets are equity-financed.
Innovotech Inc - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Innovotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check IOT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Innovotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Innovotech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pensionbee Group PLC
LSE:PBEE
|
-0.036x |
|
Activate Energy Acquisition Corp. Warrant
NASDAQ:AEAQW
|
N/A |
|
BELLUSCURA PLC LS -01
F:9VQ
|
N/A |
|
DEFSEC Technologies Inc.
NASDAQ:DFSC
|
-0.430x |
|
Big Tree Cloud Holdings Limited Ordinary Shares
NASDAQ:DSY
|
-0.225x |
|
XP Chemistries AB
ST:XPC
|
-0.113x |
|
Future PLC
LSE:FUTR
|
0.068x |
|
Golden Goliath Resources Ltd.
V:GNG
|
-0.262x |
Annual Cash Flow Conversion Efficiency for Innovotech Inc (2003–2025)
The table below shows the annual cash flow conversion efficiency of Innovotech Inc from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see IOT market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$3.65 Million ≈ $2.64 Million |
CA$-62.35K ≈ $-45.11K |
-0.017x | +45.09% |
| 2024-12-31 | CA$2.62 Million ≈ $1.90 Million |
CA$-81.64K ≈ $-59.06K |
-0.031x | +86.37% |
| 2023-12-31 | CA$998.60K ≈ $722.37K |
CA$-228.08K ≈ $-164.99K |
-0.228x | -215.91% |
| 2022-12-31 | CA$1.06 Million ≈ $764.99K |
CA$208.39K ≈ $150.75K |
0.197x | +826.07% |
| 2021-12-31 | CA$1.18 Million ≈ $851.37K |
CA$25.04K ≈ $18.12K |
0.021x | -92.17% |
| 2020-12-31 | CA$644.98K ≈ $466.57K |
CA$175.24K ≈ $126.76K |
0.272x | -65.07% |
| 2019-12-31 | CA$98.09K ≈ $70.95K |
CA$76.30K ≈ $55.19K |
0.778x | +125.90% |
| 2018-12-31 | CA$93.47K ≈ $67.61K |
CA$-280.75K ≈ $-203.09K |
-3.004x | -243.54% |
| 2017-12-31 | CA$181.51K ≈ $131.30K |
CA$-158.69K ≈ $-114.80K |
-0.874x | -45878.85% |
| 2016-12-31 | CA$-1.22 Million ≈ $-881.43K |
CA$2.32K ≈ $1.68K |
-0.002x | +95.34% |
| 2015-12-31 | CA$-1.00 Million ≈ $-725.51K |
CA$40.90K ≈ $29.58K |
-0.041x | -135.58% |
| 2014-12-31 | CA$-765.66K ≈ $-553.87K |
CA$-87.75K ≈ $-63.48K |
0.115x | -88.37% |
| 2013-12-31 | CA$-569.33K ≈ $-411.85K |
CA$-560.96K ≈ $-405.79K |
0.985x | +6432.59% |
| 2003-12-31 | CA$836.94K ≈ $605.43K |
CA$-13.02K ≈ $-9.42K |
-0.016x | -171.08% |
| 2003-09-30 | CA$841.40K ≈ $608.65K |
CA$18.42K ≈ $13.32K |
0.022x | -- |
About Innovotech Inc
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assa… Read more